These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12813810)

  • 61. The changing impact of HIV/AIDS on Kenyatta National Hospital, Nairobi from 1988/89 through 1992 to 1997.
    Arthur G; Bhatt SM; Muhindi D; Achiya GA; Kariuki SM; Gilks CF
    AIDS; 2000 Jul; 14(11):1625-31. PubMed ID: 10983650
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhancing the treatment of HIV/AIDS with Reiki training and treatment.
    Schmehr R
    Altern Ther Health Med; 2003; 9(2):120, 118. PubMed ID: 12652892
    [No Abstract]   [Full Text] [Related]  

  • 63. Prevention is treatment: prevention with positives in clinical care.
    Patt MR
    HRSA Careaction; 2003 Mar; ():1-8. PubMed ID: 12809087
    [No Abstract]   [Full Text] [Related]  

  • 64. Antiretroviral therapeutics.
    Portegies P
    J Neurovirol; 2002 Dec; 8 Suppl 2():148-50. PubMed ID: 12491167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme.
    Needham DM; Hogg RS; Yip B; O'Shaughnessy M; Schechter MT; Montaner JS
    Int J STD AIDS; 1998 Jun; 9(6):370-2. PubMed ID: 9671257
    [No Abstract]   [Full Text] [Related]  

  • 66. [Mobilizing the defense mechanisms of infected patients. What chance do immunotherapeutic approaches have?].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():78-9. PubMed ID: 12043084
    [No Abstract]   [Full Text] [Related]  

  • 67. [Admissions and mortality changes in a third-level care Hospital Internal Medicine Department (1996-2000). Influence of the modifications in the HIV infection treatment].
    Brun Romero FM; Martín Aspas A; Guerrero Sánchez F; Montes de Oca Arjona M; Soto Cárdenas MJ; Girón González JA
    Rev Clin Esp; 2005 Feb; 205(2):51-6. PubMed ID: 15766475
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of highly active antiretroviral therapy on outcomes in Veterans Affairs Medical Centers.
    Bidwell Goetz M; Morreale AP; Rhew DC; Berman S; Ing M; Eldridge D; Justis JC; Lott E
    AIDS; 2001 Mar; 15(4):530-2. PubMed ID: 11242153
    [No Abstract]   [Full Text] [Related]  

  • 69. Pharmacotherapy of Hospitalised HIV-Infected Patients in a General Hospital during 1990, 1997 and 2001.
    de Maat MM; Post TM; Jonker DM; Mulder JW; Meenhorst PL; van Gorp EC; Koks CH; de Boer A; Beijnen JH
    Clin Drug Investig; 2003; 23(1):45-53. PubMed ID: 23319093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. WHO welcomes research showing effectiveness of AIDS treatment.
    S Afr Med J; 2003 Dec; 93(12):896. PubMed ID: 14750486
    [No Abstract]   [Full Text] [Related]  

  • 71. XIIIth International AIDS Conference: new thoughts on old drugs.
    Laurence J
    AIDS Patient Care STDS; 2000 Sep; 14(9):457-9. PubMed ID: 11051627
    [No Abstract]   [Full Text] [Related]  

  • 72. HIV outcomes: natural history of HIV and economic impact.
    Moore RD
    Hopkins HIV Rep; 1999 Nov; 11(6):3, 10. PubMed ID: 12182138
    [No Abstract]   [Full Text] [Related]  

  • 73. [Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies].
    Pérez-Hoyos S
    Med Clin (Barc); 2006 Jul; 127(5):175-6. PubMed ID: 16834953
    [No Abstract]   [Full Text] [Related]  

  • 74. [Lead time bias and its control in observational studies for clinical outcomes].
    Zhang N; Liu HX; Kang DM; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):700-703. PubMed ID: 29860822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral presentation abstracts from the 13th International Symposium on HIV and Emerging Infectious Diseases (ISHEID). June 3-5, 2004. Toulon, France.
    HIV Clin Trials; 2004; 5(5):323-56. PubMed ID: 15562372
    [No Abstract]   [Full Text] [Related]  

  • 76. [Analysis of operating costs during a year in an infectious diseases department (April '94-March '95)].
    Sabbatani S; Di Crescenzo E; Ribani L
    Infez Med; 1996; 4(1):19-31. PubMed ID: 14967968
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 2nd International Congress on Drug Therapy in HIV Infection. Glasgow, Scotland, 18-22 November 1994. Abstracts.
    AIDS; 1994 Nov; 8 Suppl 4():S1-57. PubMed ID: 7865164
    [No Abstract]   [Full Text] [Related]  

  • 78. Glasgow HIV conference on HIV Drug Therapy 2020.
    Barber TJ; Waters LJ
    J Virus Erad; 2021 Mar; 7(1):100031. PubMed ID: 33659068
    [No Abstract]   [Full Text] [Related]  

  • 79. International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.
    J Int AIDS Soc; 2016; 19(8(Suppl 7)):21487. PubMed ID: 27780519
    [No Abstract]   [Full Text] [Related]  

  • 80. Highlights of the International Congress on Drug Therapy in HIV Infection, 23-26 October 2016, Glasgow, UK.
    Montaner J; Rojo P; Anand T; Rockstroh J
    J Virus Erad; 2017 Apr; 3(2):97-100. PubMed ID: 28435695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.